MedTrace Logo

The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis

NCT03105505 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2018-01-30

No results posted yet for this study

Summary

The study aims to investigate the effect of Permethrin 5% treatment on Signs and symptoms of Demodex-blepharitis in comparison to Synthomycine 5% and Fucithalmic (fusidic acid 1%) .

Conditions

  • Inflammation of the Eyelids

Interventions

DRUG

Permethrin 5%

Facial skin application once a night for 3 months.

DRUG

Synthomycine 5%

Eye ointment, eyelids and eyelashes application (chloramphenicol), once a night for 3 months.

DRUG

Fusidic Acid 1% M/R Eye Drops

viscous eye drops application once a night for 3 months.

Sponsors & Collaborators

  • Barzilai Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-28
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105505 on ClinicalTrials.gov